Fluent BioSciences

fluentbio.com

Fluent BioSciences is a leading life sciences company focused on revolutionizing single-cell analysis through its proprietary PIPseq™ technology. This innovative platform enables sensitive and unbiased preparation of proteins and nucleic acids for sequencing applications, making single-cell analysis accessible and cost-effective for laboratories without the need for complex instrumentation. Fluent's products, including various PIPseq™ kits, cater to diverse applications in cancer, immunology, neuroscience, and infectious disease research. The company has gained traction in the market, evidenced by its acquisition by Illumina, and is well-positioned to capitalize on the growing demand for single-cell analysis solutions in the biotech and pharmaceutical sectors.